Endo Pharmaceuticals Provides Regulatory Update on AVEED injectionEndo Pharmaceuticals announced that it received a complete response the U order propecia read more .S. Food and the U.S. Food and Drug Administration on the New Drug Application for its extended duration testosterone undecanoate injection AVEED , for men with low testosterone. Low testosterone is also known as hypogonadism.

In the complete response letter, the information information from Endo Agency concerns about rare but serious adverse events, including post-injection anaphylactic reaction and pulmonary oil microembolism address. The letter also stated Risk Evaluation Risk Evaluation and Mitigation Strategy is sufficient.

prescription medication

This technology crops If top choice for farmers globally.

Over MacugenMacugen, a selective inhibitor VEGF-165, is in the U.S. For the treatment of of neovascular age -related macular degeneration and be permitted each in a 0.3 mg dose even administered six weeks through intravitreal injection. Macugen is a pegylated anti-VEGF aptamers binding to vascular endothelial growth factor . VEGF is a protein Inch neovascular AMD. Crucial role in the angiogenesis and increased transmission , two pathological processes occurring to contribute does in loss of vision associated with neovascular AMD.